Excellent post-transplant survival in patients with intermediate stage hepatocellular carcinoma responding to neoadjuvant therapy

Finkenstedt Armin; Vikoler Anja; Portenkirchner Manuela; Muelleder Kerstin; Maglione Manuel; Margreiter Christian; Moser Patrizia; Vogel Wolfgang; Bale Reto; Freund Martin; Luger Anna; Tilg Herbert; Petersen Johannes; Schneeberger Stefan; Graziadei Ivo; Zoller Heinz; Glodny Bernhard

首页> 外文期刊>Liver international : >Excellent post-transplant survival in patients with intermediate stage hepatocellular carcinoma responding to neoadjuvant therapy

【24h】

Excellent post-transplant survival in patients with intermediate stage hepatocellular carcinoma responding to neoadjuvant therapy

机译：中期肝细胞癌患者对Neoadjuvant治疗患者的优异后移植存活

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Background & AimsCurrent treatment guidelines preclude liver transplantation for patients with BCLC B (intermediate stage) HCC, and expanding transplantation criteria for selected patients beyond early stage HCC remains controversial. The aim of this study was to determine stage-dependent HCC recurrence and overall survival rates in transplant recipients and the impact of response to neoadjuvant treatment on outcome.

机译：背景和AIM激流治疗指南妨碍BCLC B（中间阶段）HCC患者的肝移植，并扩大了早期HCC早期患者的移植标准仍存在争议。本研究的目的是确定移植受者的阶段依赖的HCC复发和整体存活率以及对结果对新辅助治疗的影响。

著录项

来源
《Liver international :》 |2016年第5期|共8页
作者
Finkenstedt Armin; Vikoler Anja; Portenkirchner Manuela; Muelleder Kerstin; Maglione Manuel; Margreiter Christian; Moser Patrizia; Vogel Wolfgang; Bale Reto; Freund Martin; Luger Anna; Tilg Herbert; Petersen Johannes; Schneeberger Stefan; Graziadei Ivo; Zoller Heinz; Glodny Bernhard;
展开▼
作者单位

Med Univ Innsbruck Dept Med Gastroenterol &

Hepatol 2 Anichstr 35 A-6020 Innsbruck Austria;

Med Univ Innsbruck Dept Med Gastroenterol &

Hepatol 2 Anichstr 35 A-6020 Innsbruck Austria;

Med Univ Innsbruck Dept Radiol A-6020 Innsbruck Austria;

Med Univ Innsbruck Dept Radiol A-6020 Innsbruck Austria;

Med Univ Innsbruck Dept Transplant Surg A-6020 Innsbruck Austria;

Med Univ Innsbruck Dept Transplant Surg A-6020 Innsbruck Austria;

Med Univ Innsbruck Dept Pathol A-6020 Innsbruck Austria;

Med Univ Innsbruck Dept Med Gastroenterol &

Hepatol 2 Anichstr 35 A-6020 Innsbruck Austria;

Med Univ Innsbruck Dept Radiol A-6020 Innsbruck Austria;

Med Univ Innsbruck Dept Radiol A-6020 Innsbruck Austria;

Med Univ Innsbruck Dept Radiol A-6020 Innsbruck Austria;

Med Univ Innsbruck Dept Med Gastroenterol &

Hepatol 1 A-6020 Innsbruck Austria;

Med Univ Innsbruck Dept Radiol A-6020 Innsbruck Austria;

Med Univ Innsbruck Dept Transplant Surg A-6020 Innsbruck Austria;

Acad Teaching Hosp Hall Tirol Dept Internal Med Hall In Tirol Austria;

Med Univ Innsbruck Dept Med Gastroenterol &

Hepatol 2 Anichstr 35 A-6020 Innsbruck Austria;

Med Univ Innsbruck Dept Radiol A-6020 Innsbruck Austria;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内科学;
关键词
Hepatoma; liver transplantation; Milan criteria;

机译：肝癌;肝移植;米兰标准;

相似文献

外文文献
中文文献
专利

1. Excellent post-transplant survival in patients with intermediate stage hepatocellular carcinoma responding to neoadjuvant therapy [J] . Finkenstedt Armin, Vikoler Anja, Portenkirchner Manuela, Liver international : . 2016,第5期

机译：对新辅助治疗有反应的中级肝细胞癌患者具有出色的移植后存活率
2. Hepatic arterial infusion chemotherapy with fine-powder cisplatin and iodized-oil suspension in patients with intermediate-stage and advanced-stage (Barcelona Clinic Liver Cancer stage-B or stage-C) hepatocellular carcinoma: multicenter phase-II clinical study [J] . Takaki Haruyuki, Yamakado Koichiro, Tsurusaki Masakatsu, International journal of clinical oncology . 2015,第4期

机译：肝癌中晚期患者（Barcelona临床肝癌B期或C期）肝癌细粉顺铂加碘油悬浮液的肝动脉灌注化疗：多中心II期临床研究
3. Hepatic arterial infusion chemotherapy with fine-powder cisplatin and iodized-oil suspension in patients with intermediate-stage and advanced-stage (Barcelona Clinic Liver Cancer stage-B or stage-C) hepatocellular carcinoma: multicenter phase-II clinical study [J] . Takaki Haruyuki, Yamakado Koichiro, Tsurusaki Masakatsu, International journal of clinical oncology . 2015,第4期

机译：肝动脉输液化疗用细粉顺铂和碘油悬浮液中中期和先进阶段（巴塞罗那临床肝癌阶段-B或Stage-C）肝癌：多中心期 - II临床研究
4. Fewer Somatic Mutations of Mitochondrial Dna in Noncancerous Liver Tissue of Patients With Hepatocellular Carcinoma Respond To interferon therapy [C] . Shuhei Nishiguchi, Manabk Nishikawa, Masayasu inoue, Yamaguchi Symposium on Liver Disease . 2003

机译：肝细胞癌患者的非癌症肝组织中的线粒体DNA的细胞突变较少，对干扰素治疗反应
5. Mechanisms of Cell Death and Survival to Heat Stress Resulting from Thermal Ablation of Hepatocellular Carcinoma [D] . Thompson, Scott Michael 2015

机译：肝细胞癌热消融引起热应激的细胞死亡和存活机制
6. Comparison of survival among neoadjuvant chemoradiation responders non-responders and patients receiving primary resection for locally advanced oesophageal squamous cell carcinoma: does neoadjuvant chemoradiation benefit all? [O] . Po-Kuei Hsu, Ling-I Chien, Chien-Sheng Huang, -1

机译：比较新辅助化学放疗反应者无反应者和接受局部切除的局部晚期食管鳞状细胞癌患者：新辅助化学放疗对所有人都有好处吗？
7. Lenvatinib prolongs the progression‑free survival time of patients with intermediate‑stage hepatocellular carcinoma refractory to transarterial chemoembolization: A multicenter cohort study using data mining analysis [O] . Shigeo Shimose, Takumi Kawaguchi, Masatoshi Tanaka, 2020

机译：Lenvatinib延长了患者中期肝细胞癌难治性的无进展生存时间令人难以理解的ryarterial Chemoembolization：使用数据挖掘分析的多中心队列研究

Excellent post-transplant survival in patients with intermediate stage hepatocellular carcinoma responding to neoadjuvant therapy

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅